Home/All Molecules/Silymarin

Silymarin Range

Comprehensive Silymarin portfolio for Franchise & Manufacturing.

Category
silymarin
Total Formulations
9
Available Forms
Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Silymarin portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Silymarin batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Silymarin PCD Pharma Franchise Company

Silymarin PCD Pharma Franchise Company

Cafoli Lifecare is a reliable Silymarin PCD pharma franchise company in India, offering 9 Silymarin formulations across syrups and tablets. All products are manufactured in WHO-GMP certified facilities, giving franchise partners a dependable hepatoprotective range for gastro and general practice prescribing.

What is Silymarin?

Silymarin is a standardised extract obtained from the seeds of milk thistle (Silybum marianum) and consists mainly of flavonolignans such as silybin, silydianin and silychristin. It acts as an antioxidant and membrane stabiliser in hepatocytes, and is used clinically as a supportive hepatoprotective agent in chronic liver conditions. Compound details are catalogued on PubChem.

Therapeutic Applications of Silymarin

Silymarin is used as adjuvant therapy in non-alcoholic and alcoholic fatty liver disease, chronic hepatitis, drug-induced liver injury and as liver support during hepatotoxic drug regimens. It is prescribed chiefly by gastroenterologists and hepatologists, and very widely by consulting physicians and general practitioners managing deranged liver function tests.

Why Silymarin is a High-Potential Molecule for Distributors

Silymarin sits in a rare commercial sweet spot: it is a prescription-driven hepatoprotective with an excellent tolerability record, so physicians add it freely without the monitoring burden of harder drugs. With fatty liver now detected routinely on abdominal ultrasound in urban India, the prescribing base has widened from specialists to every general physician. It is also stacked onto long-duration regimens such as anti-tubercular therapy, meaning each patient generates months of continuous demand rather than a single course.

Why Choose Cafoli Lifecare

We appoint partners on a true district monopoly basis, manufacture in WHO-GMP certified units with DCGI-approved compositions, and back every partner with promotional inputs including visual aids, samples, prescription pads and MR bags. Over 1000+ franchise partners across India already trust Cafoli Lifecare.

References

  1. PubChem – Silymarin compound record
  2. MedlinePlus – Silymarin information
  3. PubMed – clinical literature on Silymarin

Aceclofenac in Modern Clinical Practice

Our formulations of Silymarin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Silymarin in PCD Franchise

Start Your Silymarin Franchise with Cafoli Lifecare

Ready to build your own Silymarin distribution business? Cafoli Lifecare offers monopoly-based PCD pharma franchise rights, WHO-GMP certified manufacturing and complete promotional support. Call 9518447302 or email info@cafoli.in to check district availability and receive our latest price list.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare lists 9 Silymarin formulations, available as tablets and syrups, including combinations commonly used in liver-support therapy. The full composition-wise list with packing and pricing is shared on enquiry.

Yes. Silymarin is offered on a district monopoly basis, so only one Cafoli franchise partner is appointed per territory. Availability is confirmed once your Drug License is verified.

Silymarin is prescribed by gastroenterologists and hepatologists, and widely by consulting physicians who manage fatty liver, alcoholic liver disease and drug-induced liver injury.

Non-alcoholic fatty liver disease is now extremely common in urban India, and Silymarin is one of the most frequently added hepatoprotective adjuvants in these patients. It is also co-prescribed alongside long-course anti-tubercular and antifungal therapy, which creates demand from outside gastroenterology alone.

A valid Drug License and GST registration number are required to begin the appointment process with Cafoli Lifecare.